CIK 0001501796 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Aura Biosciences, Inc.
Sign in to watch- Ticker
- AURA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 320271970
- Phone
- (617)500-8864
- Business address
- 80 GUEST STREET, BOSTON, MA, 02135
- 8-K Event Results of operations · Other events
- 4 Grant or award Director acquired 10,500 shares (grant or award)
- 4 Grant or award Director acquired 10,500 shares (grant or award)
- 4 Grant or award Director acquired 10,500 shares (grant or award)
- 8-K Event Bylaws or fiscal year change · Shareholder vote results
- DEFA14A Proxy Proxy Materials
- 10-K/A Report 10-K/A
- 8-K Event Other events
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 8-K Event Executive or director change
- PRE 14A Proxy Proxy Statement (Preliminary)
- EFFECT Other Notice of Effectiveness
- 4 Grant or award General Counsel and Secretary acquired 96,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
Page 10 of 20 · 383 filings